Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CGS 15855A

Known as: 2H-(1)Benzopyrano(3,4-b)pyridin-9-ol, 1,3,4,4a,5,10b-hexahydro-4-propyl-, trans-(+-)-, CGS-15855-A, CGS-15855A 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1998
Highly Cited
1998
In the present study, a novel and exceptionally sensitive method of high-performance liquid chromatography coupled to coulometric… Expand
Is this relevant?
1995
1995
The preferential dopamine (DA) D3 versus D2 receptor agonist, (+)-7-OH-DPAT, dose-dependently decreased DA synthesis in the… Expand
Is this relevant?
1995
1995
Using [125I]-iodosulpride as a radioligand, the novel naphthofurane, (+/-)-S 11566 [(+/-)-[7-(N,N-dipropylamino)-5,6,7,8-tetra… Expand
Is this relevant?
1992
1992
Previous work has indicated that the neurotoxic action of environmentally relevant levels of lead (Pb) on dopaminergic neurons is… Expand
Is this relevant?
1989
1988
1988
The metabolism and release of dopamine by rat mesostriatal and mesolimbic dopamine neurons were determined after 2 or 14 days of… Expand
Is this relevant?
1988
1988
Qualitative differences in pharmacological responsiveness to various types of dopamine agonists have been reported in rats that… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
1987
1987
The ability of dopamine autoreceptor agonists to suppress the in vivo release or metabolism of dopamine in mouse brain was… Expand
Is this relevant?
1987
1987
The capacity of D1 and D2 agonists and antagonists to regulate the in vivo release and metabolism of dopamine (DA) in mesolimbic… Expand
Is this relevant?
1987
1987
The regulation by autoreceptors of dopamine release in the rat neocortex was inferred from measurements of 3-methoxytyramine… Expand
Is this relevant?